Copyright Reports & Markets. All rights reserved.

Global Antivirals Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Antivirals

      • 1.1 Definition of Antivirals
      • 1.2 Antivirals Segment by Type
        • 1.2.1 Global Antivirals Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Generic
        • 1.2.3 Branded
      • 1.3 Antivirals Segment by Applications
        • 1.3.1 Global Antivirals Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Application I
        • 1.3.3 HIV
        • 1.3.4 Hepatitis
        • 1.3.5 HSV
        • 1.3.6 Influenza
      • 1.4 Global Antivirals Overall Market
        • 1.4.1 Global Antivirals Revenue (2014-2025)
        • 1.4.2 Global Antivirals Production (2014-2025)
        • 1.4.3 North America Antivirals Status and Prospect (2014-2025)
        • 1.4.4 Europe Antivirals Status and Prospect (2014-2025)
        • 1.4.5 China Antivirals Status and Prospect (2014-2025)
        • 1.4.6 Japan Antivirals Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Antivirals Status and Prospect (2014-2025)
        • 1.4.8 India Antivirals Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Antivirals
      • 2.3 Manufacturing Process Analysis of Antivirals
      • 2.4 Industry Chain Structure of Antivirals

      3 Development and Manufacturing Plants Analysis of Antivirals

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Antivirals Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Antivirals
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Antivirals Production and Capacity Analysis
      • 4.2 Antivirals Revenue Analysis
      • 4.3 Antivirals Price Analysis
      • 4.4 Market Concentration Degree

      5 Antivirals Regional Market Analysis

      • 5.1 Antivirals Production by Regions
        • 5.1.1 Global Antivirals Production by Regions
        • 5.1.2 Global Antivirals Revenue by Regions
      • 5.2 Antivirals Consumption by Regions
      • 5.3 North America Antivirals Market Analysis
        • 5.3.1 North America Antivirals Production
        • 5.3.2 North America Antivirals Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Antivirals Import and Export
      • 5.4 Europe Antivirals Market Analysis
        • 5.4.1 Europe Antivirals Production
        • 5.4.2 Europe Antivirals Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Antivirals Import and Export
      • 5.5 China Antivirals Market Analysis
        • 5.5.1 China Antivirals Production
        • 5.5.2 China Antivirals Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Antivirals Import and Export
      • 5.6 Japan Antivirals Market Analysis
        • 5.6.1 Japan Antivirals Production
        • 5.6.2 Japan Antivirals Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Antivirals Import and Export
      • 5.7 Southeast Asia Antivirals Market Analysis
        • 5.7.1 Southeast Asia Antivirals Production
        • 5.7.2 Southeast Asia Antivirals Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Antivirals Import and Export
      • 5.8 India Antivirals Market Analysis
        • 5.8.1 India Antivirals Production
        • 5.8.2 India Antivirals Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Antivirals Import and Export

      6 Antivirals Segment Market Analysis (by Type)

      • 6.1 Global Antivirals Production by Type
      • 6.2 Global Antivirals Revenue by Type
      • 6.3 Antivirals Price by Type

      7 Antivirals Segment Market Analysis (by Application)

      • 7.1 Global Antivirals Consumption by Application
      • 7.2 Global Antivirals Consumption Market Share by Application (2014-2019)

      8 Antivirals Major Manufacturers Analysis

      • 8.1 Merck
        • 8.1.1 Merck Antivirals Production Sites and Area Served
        • 8.1.2 Merck Product Introduction, Application and Specification
        • 8.1.3 Merck Antivirals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Johnson & Johnson
        • 8.2.1 Johnson & Johnson Antivirals Production Sites and Area Served
        • 8.2.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.2.3 Johnson & Johnson Antivirals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Teva Pharmaceutical Industries
        • 8.3.1 Teva Pharmaceutical Industries Antivirals Production Sites and Area Served
        • 8.3.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
        • 8.3.3 Teva Pharmaceutical Industries Antivirals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 GSK
        • 8.4.1 GSK Antivirals Production Sites and Area Served
        • 8.4.2 GSK Product Introduction, Application and Specification
        • 8.4.3 GSK Antivirals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Mylan
        • 8.5.1 Mylan Antivirals Production Sites and Area Served
        • 8.5.2 Mylan Product Introduction, Application and Specification
        • 8.5.3 Mylan Antivirals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Gilead Sciences
        • 8.6.1 Gilead Sciences Antivirals Production Sites and Area Served
        • 8.6.2 Gilead Sciences Product Introduction, Application and Specification
        • 8.6.3 Gilead Sciences Antivirals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 F. Hoffmann-La Roche
        • 8.7.1 F. Hoffmann-La Roche Antivirals Production Sites and Area Served
        • 8.7.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
        • 8.7.3 F. Hoffmann-La Roche Antivirals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Bristol-Myers-Squibb
        • 8.8.1 Bristol-Myers-Squibb Antivirals Production Sites and Area Served
        • 8.8.2 Bristol-Myers-Squibb Product Introduction, Application and Specification
        • 8.8.3 Bristol-Myers-Squibb Antivirals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 AbbVie
        • 8.9.1 AbbVie Antivirals Production Sites and Area Served
        • 8.9.2 AbbVie Product Introduction, Application and Specification
        • 8.9.3 AbbVie Antivirals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Aurobindo Pharma
        • 8.10.1 Aurobindo Pharma Antivirals Production Sites and Area Served
        • 8.10.2 Aurobindo Pharma Product Introduction, Application and Specification
        • 8.10.3 Aurobindo Pharma Antivirals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Cipla
      • 8.12 Dr Reddy’s

      9 Development Trend of Analysis of Antivirals Market

      • 9.1 Global Antivirals Market Trend Analysis
        • 9.1.1 Global Antivirals Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Antivirals Regional Market Trend
        • 9.2.1 North America Antivirals Forecast 2019-2025
        • 9.2.2 Europe Antivirals Forecast 2019-2025
        • 9.2.3 China Antivirals Forecast 2019-2025
        • 9.2.4 Japan Antivirals Forecast 2019-2025
        • 9.2.5 Southeast Asia Antivirals Forecast 2019-2025
        • 9.2.6 India Antivirals Forecast 2019-2025
      • 9.3 Antivirals Market Trend (Product Type)
      • 9.4 Antivirals Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Antivirals Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.

        The global Antivirals market was valued at 46000 million US$ in 2018 and will reach 65400 million US$ by the end of 2025, growing at a CAGR of 4.5% during 2019-2025.
        This report focuses on Antivirals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antivirals market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Antivirals in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Antivirals manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Merck
        Johnson & Johnson
        Teva Pharmaceutical Industries
        GSK
        Mylan
        Gilead Sciences
        F. Hoffmann-La Roche
        Bristol-Myers-Squibb
        AbbVie
        Aurobindo Pharma
        Cipla
        Dr Reddy’s

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Generic
        Branded

        Segment by Application
        Application I
        HIV
        Hepatitis
        HSV
        Influenza

        Buy now